Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Type: Information update
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 69 items.
Plasma pens are not authorized in Canada and may pose health risks
AlertInformation update | 2022-05-11
Ranitidine products recalled because of a nitrosamine impurity
AlertInformation update | 2022-03-11
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
AlertInformation update | 2020-10-27
Information Update - Use of the drug Picato may increase the risk of skin cancer
AlertInformation update | 2020-07-02
Medical Device Respirator recalls
AlertInformation update | 2020-06-23
Certain Metformin diabetes drugs recalled due to the presence or possible presence of NDMA
AlertInformation update | 2020-06-13
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20
Cybersecurity vulnerabilities associated with some medical devices with Bluetooth Low Energy chips
AlertInformation update | 2020-03-11
Alcohol, Cannabis and Drug Use During the Holiday Season
AlertInformation update | 2019-12-17
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
Health Canada clarification: laser-based medical devices are not licensed in Canada to cure fungal nail infections
AlertInformation update | 2019-12-05
Health Canada reminds Canadians of the dangers of unauthorized health products; it will not hesitate to take enforcement action if needed
AlertInformation update | 2019-12-04
Health Canada updates Canadians on its ongoing assessment of nitrosamine impurities in certain drugs
AlertInformation update | 2019-12-02